Certara

Certara EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Certara (CERT) as of Oct 19, 2026 is 27.35 M USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 51.86 M USD — a change of -47.26% (lower).

EBITDA

27.35 MUSD

YoY

-47.26%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Certara is 2025 27.35 M USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Certara was 2024 51.86 M USD. It decreases by -47.26% lower compared to the previous year.

The Certara EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
29.35 M USD
Jan 1, 2019
58.41 M USD
Jan 1, 2020
15.01 M USD
Jan 1, 2021
54.48 M USD
Jan 1, 2022
75.72 M USD
Jan 1, 2023
13.30 M USD
Jan 1, 2024
51.86 M USD
Jan 1, 2025
27.35 M USD
The Certara EBITDA history
YEAREBITDAYoY
27.35 MUSD-47.26%
51.86 MUSD+290.00%
13.30 MUSD-82.44%
75.72 MUSD+38.99%
54.48 MUSD+262.83%
15.01 MUSD-74.30%
58.41 MUSD+99.04%
29.35 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Certara Stock analysis

What does Certara do? Certara Inc. is a company specializing in the development of innovative solutions for the pharmaceutical industry. It offers a wide range of services and products to support its customers in all phases of drug development. The company was formed in 2008 through the merger of Tripos International and Pharsight Corporation. It combines expertise in software development, modeling and simulation, and offers solutions to the pharmaceutical industry's challenges. Certara provides services in modeling and simulation, analysis software development, pharmacokinetics, and regulatory support. Its products include software solutions like Knowledgebase for Clinical Trials, Phoenix modeling software, and Simcyp analysis software. The company also offers training and educational programs to provide customers with necessary knowledge. Certara focuses on integrity, transparency, and scientific approach in its offerings. Certara is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Certara stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Certara is 27.35 M USD in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Certara changed from 51.86 M USD to 27.35 M USD, representing a -47.26% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Certara since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Certara historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Certara

All Key Metrics — Certara